adminの記事一覧

Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucoselowering-independent manner.

BMJ Open Diabetes Res Care. 2017PubMed

Urinary Liver-Type Fatty Acid-Binding Protein Level as a Predictive Biomarker of Acute Kidney Injury in Patients with Acute Decompensated Heart Failure.

Cardiorenal Med. 2017PubMed

Prediction of contrast induced acute kidney injury using novel biomarkers following contrast coronary angiography.

QJM. 2018PubMed

Role of bardoxolone methyl, a nuclear factor erythroid 2-related factor 2 activator, in aldosterone- and salt-induced renal injury.

Hypertens Res. 2017PubMed

Renoprotective effect of the xanthine oxidoreductase inhibitor Topiroxostat under decreased angiotensin II type 1a receptor expression.

Eur J Pharmacol. 2017PubMed

Urinary liver-type fatty acid-binding protein is associated with subendocardial viability ratio in middle- and older-aged adults.

Clin Exp Hypertens. 2017PubMed

Urinalysis findings and urinary kidney injury biomarker concentrations.

BMC Nephrol. 2017PubMed

Values of combination of urinary L-FABP and NGAL in early diagnosis of acute kidney injury after cardiac surgery in children.

Scand J Clin Lab Invest. 2017PubMed

Urine liver fatty acid binding protein and chronic kidney disease progression.

Scand J Clin Lab Invest. 2017PubMed

Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes.

Diabetologia. 2017 PubMed